Novartis News

Artesunate will be administered to Covid-19 patients intravenously for seven days Imatinib will be given once daily for 14 days Infliximab will be injected in one single dose

It said the all-cash deal was approved unanimously by the boards of both firms.

The deal is set to complete in the second quarter subject to the necessary approvals.

Gene therapy is a treatment that uses a patient`s own immune cells to fight leukemia.

Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.

Results in 10 overweight and obese men suggest that one way oxytocin lowers food intake might be by improving self-control, said co-investigator Franziska Plessow of the Massachusetts General Hospital, Boston.

Vildagliptin is available as monotherapy and in combination with metformin. Both the drugs commands over 30 percent of the DPP-IV market in the UAE.

Novartis admitted that it gave specialty pharmacies exceptional rebates and patient referrals in exchange for recommending Exjade.

The Foreign Investment Promotion Board (FIPB) has approved the proposal made by GSK CPL to acquire the company's OTC division, Novartis India said in a BSE filing.

GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.

Swiss drugmaker Novartis on Thursday posted declining sales in the first quarter and cautioned that dollar strength may be a bigger-than-expected drag on full-year figures.

GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.

Drug firm Novartis India Ltd on Wednesday reported a net loss of Rs 1.18 crore for the third quarter ended December 31, 2014.

The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.

Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.

Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.

Fair trade regulator CCI has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it did not find the transaction to be anti-competitive ion India.

The Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease.